Minority patient groups—including those whose primary language is not English and those who have lower middle-income economic status—with a diagnosis
Month: April 2022
Blood type may offer insights into risk of blood clot in people with cancer
A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face
New insights into the mechanisms that enable cancer cells to metastasize
Cancer is at its most deadly when it spreads and forms tumors in new tissues. This process, called metastasis, is
A small mutation can make Zika virus even more dangerous
Researchers at La Jolla Institute for Immunology (LJI) have found that Zika virus can mutate to become more infective—and potentially
Using electricity to treat cancer
Electricity has formed the basis of many aspects of the modern world, from providing reliable sources of light to powering
Hard to change minds when it comes to vaccine willingness
In the fall of 2020, before vaccines were readily available, the Canadian Longitudinal Study on Aging (CLSA) surveyed nearly 24,000
Maxillofacial surgeons develop AI-based web tool to predict oral cancer risk
Oral cancer is a common cancer that affects the head and neck region. Around 50% of oral cancer patients do
Myopericarditis following COVID-19 vaccination is rare, finds international study
The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new
Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy
Scientists from the University of Sheffield have discovered a drug already used to treat lung cancer could help to improve
Exposure to a group of widely used ‘forever chemicals’ may increase diabetes risk in middle-aged women
A new study published in Diabetologia finds that exposure to per- and polyfluoroalkyl substances (PFAS)—a large and diverse group of industrial chemicals